The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases.
Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. · 2021
Read The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. by Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8066304.txt.
Introduction
Baldelli and co-authors examine the part one bacterial family plays in gut dysbiosis in bowel disease. Inflammatory bowel diseases mix genes, immune faults, and a disturbed gut flora. Helpful microbes thin out, and pathobionts expand in their place. Blooms of Enterobacteriaceae mark that shift again and again. The bloom seems to feed the inflammation itself.
The review asks why this family expands in the inflamed gut. Rising nitrate and oxygen levels in the tissue may fuel it. Disturbed bile acid handling in patients may help too. At species level, adherent-invasive E. coli stands out as a suspect. These strains cling to gut cells and invade them. The authors weigh strain-level studies against family-wide patterns. Their verdict gives this family a central role in disease course.
Catalog record
| CREATOR | Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases By Valerio Baldelli, Franco Scaldaferri, Lorenza Putignani, Federica Del Chierico, Claudio de Simone Published in: Microorganisms DOI: 10.3390/microorganisms9040697 ABSTRACT Abstract Inflammatory bowel diseases (IBDs) are a group of chronic gastrointestinal inflammatory diseases with unknown etiology. There is a combination of well documented factors in their pathogenesis, including intestinal microbiota dysbiosis. The symbiotic microbiota plays important functions in the host, and the loss of beneficial microbes could favor the expansion of microbial pathobionts. In particular, the bloom of potentially harmful Proteobacteria, especially Enterobacteriaceae, has been described as enhancing the inflammatory response, as observed in IBDs. Herein, we seek to investigate the contribution of Enterobacteriaceae to IBD pathogenesis whilst considering the continuous expansion of the literature and data. Despite the mechanism of their expansion still remaining unclear, their expansion could be correlated with the increase in nitrate and oxygen levels in the inflamed gut and with the bile acid dysmetabolism described in IBD patients. Furthermore, in several Enterobacteriaceae studies conducted at a species level, it has been suggested that some adherent-invasive Escherichia coli (AIEC) play an important role in IBD pathogenesis. Overall, this review highlights the pivotal role played by Enterobacteriaceae in gut dysbiosis associated with IBD pathogenesis and progression. Keywords: Enterobacteriaceae, microbiota, inflammation, inflammatory bowel diseases (IBDs) 1. INTRODUCTION Inflammatory bowel diseases (IBDs) are a heterogeneous group of chronic, relapsing–remitting, gastrointestinal (GI) inflammatory diseases with various degrees of damage, promoting the development of local and extra-intestinal complications. IBDs include ulcerative colitis (UC) disease and Crohn’s disease (CD); the first is restricted to the colon, while the second can affect different parts of the digestive tract [1,2]. Despite the etiology of IBDs remaining unknown, it is reported that there is an involvement of the host’s genetics, gut microbiota, and immune system [3,4,5]. Genetically susceptible individuals seem to be more prone to developing IBDs as a consequence of their atypical immune response to the autologous gut microbiota, following exposure to different environmental factors and stimuli [6,7]. Indeed, recent studies have revealed that pathologic alterations in the GI microbiota activate a mucosal immune response, thus developing chronic intestinal inflammation. These alterations in the GI microbiota trigger the so-called dysbiosis. Thus, the disruption of the intestinal eubiotic status can be considered a cause rather than simply a consequence of the chronic GI inflammation in IBDs [8,9,10,11,12]. Many studies have reported an increase in the proportion of potentially harmful Proteobacteria, especially of the Enterobacteriaceae family, in IBD patients [2,13,14,15,16,17,18,19]. Therefore, it would appear that the host’s inflammatory response could be the trigger of gut microbiota imbalance, most likely caused by Enterobacteriaceae blooming, which leads to the persistence of IBD’s inflammatory state (Figure 1). [Figure: A schematic representation of eubiosis (A) and dysbiosis (B) conditions. (A) Microbiota plays an important role in the maintenance of gut stability by: (i) producing short-chain fatty acids (SCFAs) (i.e., acetate, propionate, and butyrate), (ii) preventing the expansion in any microbial pathogens, and (iii) modulating the immune system (i.e., production of anti-inflammatory cytokines (Interleukin (IL)-10, Transforming Growth Factor (TGF)-β)) and decreasing the activation of T-helper cell (Th)17 and Th1 cells; (B) During dysbiotic conditions, bacteria belonging to the Enterobacteriaceae family could overgrow, leading to a decrease in bacterial diversity and in gut stability. This is reflected by a decrease in SCFA production, and a parallel increase in pro-inflammatory cytokines such as IL-6, IL-17, and tumor necrosis factor (TNF)-α, which activate Th17 and Th1 cells involved in the inflammation response. Moreover, a decrease in tight junctions and a subsequent loss of impermeability in the intestinal epithelium is observed.] The main aim of this review is to describe and clarify the overgrowth of Enterobacteriaceae in IBDs, especially focusing on their role during the inflammation process in relation to metabolism changes observed in the gut microbiota of IBD patients. The secondary aim is to provide an update on certain adherent-invasive Escherichia coli (AIEC) strains frequently isolated from IBD patients, and their potential role in both CD and UC disease, discussing the difficulties in the characterization at species level of Enterobacteriaceae by targeted metagenomic approaches. 2. THE ROLE OF GUT BACTERIAL MICROBIOTA IN INFLAMMATORY BOWEL DISEASES Within the GI microbiota, the most studied component is the bacterial microbiota. Humans have more than 200 different bacterial species, with highly variable abundance in the gut. Thirty percent of this population is shared by different subjects, generating the core microbiota [20,21,22]. The bacterial microbiota plays important functions in the host, such as (i) the modulation of the immune system [23], (ii) the secretion of enzymes involved in the digestion of substrates not fully accessible to the host [24], and (iii) competition with pathogenic microorganisms for the same ecological niche [25]. In this context, the functionality of the GI tract is ensured and maintained also by the gut microbiota, which plays a positive role in the preservation of the intestinal barrier [26] (Figure 1A). In particular, eubiotic microbiota is necessary to maintain the host’s immune homeostasis by the induction and function of T cells. Alterations in the gut microbiota’s composition can lead to the imbalance of T-cell subpopulations, such as Th1, Th2, Th17, and Treg cells, causing gut inflammation [27]. Numerous studies support the involvement of the GI microbiota in the pathogenesis of IBDs. Indeed, characteristic dysbiosis is often observed in subjects with CD and UC [28,29,30,31]; often, the induction or the maintenance of remission in IBDs is frequently related to the use of antibiotics and probiotics [32,33]. Several studies have demonstrated changes in microbial richness and evenness, and the relative abundance of specific bacterial taxa in IBD patients with respect to healthy subjects [34,35,36,37,38,39,40,41,42,43]. In particular, at the phylum level, the proportion of both Firmicutes and Bacteroidetes appears decreased, while the proportion of Proteobacteria and Actinobacteria is increased [13,44,45,46]. As shown by Geveres and co-workers, an increase in Veillonellaceae, Pasteurellaceae, Enterobacteriaceae, and Fusobacteriaceae, and a decrease in Bacteroidales, Erysipelotrichales, and Clostridiales, were correlated with IBDs’ clinical severity [38]. Similarly, a study on pediatric patients with CD concluded that the presence and severity of inflammation depends on microbiota dysbiosis; nonetheless, this study found an independent correlation between dysbiosis and other factors such as diet and/or the usage of antibiotics [39]. In particular, patients suffering from IBDs are associated with a decline in the abundance of protective anaerobic commensal bacteria, such as Faecalibacterium prausnitzii, Clostridium spp., and Bacteroidetes fragilis. F. prausnitzii has been shown to have anti-inflammatory properties, including the ability to modulate the host’s mucosal immune response by the production of short-chain fatty acids (SCFAs) [40]. SCFAs, such as acetate, propionate, and butyrate, are a primary energy source for colonic epithelial cells [40]. Thus, the underrepresentation of this bacterium in IBDs results in a decrease in the beneficial effects of SCFAs, including the inhibition of pro-inflammatory cytokine expression, the production of mucin and antimicrobial peptides, and tight junction protein downregulation [2,22,32,40,45,46] (Figure 1B). Moreover, the gut microbiota in IBDs is often characterized by an expansion of translocating facultative aerobic bacteria—possible pathobionts—particularly belonging to the family of Enterobacteriaceae, such as Escherichia and Shigella [13,38,47,48,49]. Pathobionts are defined as commensal microorganisms that might become pathogens in the setting of a specific environmental stimulus in genetically susceptible subjects [50]. Another bacterium